24th Jul 2020 13:20
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 23 July 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD |
|
| ||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
1,511,126 | 1.17% | 465,202 | 0.36% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
355,000 | 0.28% | 383,659 | 0.30% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
1,866,126 | 1.45% | 848,861 | 0.66% | ||
|
|
|
| ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
| Purchase | 23 | 211.7900 USD |
| Purchase | 53 | 213.3398 USD |
| Purchase | 55 | 210.8900 USD |
| Purchase | 100 | 211.3500 USD |
| Purchase | 100 | 211.9400 USD |
| Purchase | 100 | 212.1700 USD |
| Purchase | 200 | 212.0825 USD |
| Purchase | 200 | 212.2675 USD |
| Purchase | 200 | 211.9000 USD |
| Purchase | 668 | 211.9800 USD |
| Purchase | 822 | 212.2451 USD |
| Purchase | 1,715 | 212.0969 USD |
| Purchase | 4,908 | 212.0000 USD |
| Purchase | 5,350 | 211.9440 USD |
| Purchase | 6,920 | 211.9986 USD |
| Purchase | 10,481 | 211.8912 USD |
| Purchase | 11,352 | 212.0131 USD |
| Purchase | 13,041 | 211.9124 USD |
| Sale | 11 | 212.5000 USD |
| Sale | 38 | 212.8600 USD |
| Sale | 100 | 212.8500 USD |
| Sale | 100 | 211.8500 USD |
| Sale | 105 | 212.0690 USD |
| Sale | 109 | 211.9250 USD |
| Sale | 128 | 212.1684 USD |
| Sale | 234 | 211.8683 USD |
| Sale | 300 | 211.3733 USD |
| Sale | 340 | 211.3721 USD |
| Sale | 368 | 211.9257 USD |
| Sale | 593 | 211.8492 USD |
| Sale | 594 | 211.3200 USD |
| Sale | 800 | 212.2469 USD |
| Sale | 2,941 | 212.1322 USD |
| Sale | 3,504 | 212.1525 USD |
| Sale | 4,673 | 211.8922 USD |
| Sale | 4,900 | 211.9470 USD |
| Sale | 4,991 | 211.8329 USD |
| Sale | 5,652 | 212.0000 USD |
| Sale | 8,400 | 211.9707 USD |
| Sale | 16,627 | 211.9694 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | NO |
| Date of disclosure: | 24 Jul 2020 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
View source version on businesswire.com: https://www.businesswire.com/news/home/20200724005244/en/
Copyright Business Wire 2020
Related Shares:
Barclays